STRAGEN NORDIC A/S: Financial statements 2015
CVR: 26717825
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 3,437,107 and a net result of DKK -261,217 compared with DKK 171,247 the year before. That is a decrease of 19.6% compared with the year before. Equity in the 2015 report amounted to DKK 2,585,769. The solvency ratio was 45.8%.
- Gross Profit
- DKK 3,437,107
- Profit/Loss
- DKK -261,217
- Equity
- DKK 2,585,769
- Total Assets
- DKK 5,642,335
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 3.4M | -261K | 2.6M | - |
| 2014 | - | 4.3M | 171K | 2.8M | - |
| 2013 | - | 4.6M | -293K | 2.7M | - |
| 2012 | 39.5M | 2.1M | -2.8M | 3M | - |
Official annual report
How creditworthy is STRAGEN NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
STRAGEN NORDIC A/S has published its annual report for 2014. Gross profit came to DKK 4,272,586, and the net result was DKK 171,247.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
